Probiotics Linked to Better Mood in Review of 20 RCTs

If you've ever wondered whether the probiotic capsules lining the supplement aisle can actually do anything for your mood, a new review of the clinical trial evidence offers one of the most complete answers yet. Researchers combed through 227 human trials testing probiotics (dietary supplements containing live, health-supporting bacteria) against depression, anxiety, sleep problems and stress, then narrowed the pool to the 20 highest-quality randomized controlled trials, or RCTs (studies that randomly assign people to a real treatment or a placebo, considered the gold standard for testing whether a treatment actually works). Across nearly 1,916 participants, the pattern that emerged was consistent: probiotics generally helped mood, sleep and anxiety, even though the effect on stress hormones remained murky.

Key takeaways:

• A systematic review of 20 RCTs (1,916 people total) found probiotics improved depression, anxiety, sleep quality, mood and cognitive function compared with placebo.
• Gut bacterial changes tracked with the mental health improvements: 11 of the 20 studies measured the gut microbiome, and most saw increases in beneficial genera like Bifidobacterium and Lactobacillus.
• Effects on stress hormones like cortisol were inconsistent, four of seven studies found a reduction while three found none.
• Five of the 20 trials were rated high risk of bias and study designs varied widely, so the authors frame this as reason for cautious optimism, not proof of a treatment.

Systematic Review of 20 RCTs Links Probiotics to Better Mood and Sleep

A new systematic review published in the journal Annals of Neurosciences, led by researcher Das and colleagues, searched PubMed, MEDLINE, PsycINFO and ScienceDirect for randomized trials of probiotic supplementation published in the last 10 years. An initial search turned up 227 candidate trials; after excluding non-English studies, trials shorter than two weeks, and those with fewer than 20 participants, 20 RCTs met the bar. Across those 20 trials, probiotics were associated with improvements in depression (assessed in most of the studies), anxiety (10 studies), sleep quality (9 studies), mood, cognitive function and gut microbial composition (11 studies), even as effects on cortisol and other stress-related measures stayed inconsistent. This adds to a growing body of gut-brain axis research showing that the trillions of bacteria in the digestive tract communicate with the brain through the immune system, the vagus nerve and shared chemical messengers like serotonin.

Depression, Postpartum Anxiety, IBS and Alzheimer's Patients All Saw Benefits

The review's 20 trials did not just study one type of person. Six of the trials specifically recruited people with major depressive disorder, and others tested probiotics in pregnant women, older adults, athletes, and people with medical conditions such as irritable bowel syndrome (IBS) or Alzheimer's dementia. In one of the largest trials in the review, 423 pregnant women in New Zealand took the strain Lactobacillus rhamnosus HN001 or a placebo from mid-pregnancy through six months postpartum; the probiotic group had a 57% reduction in the odds of depression and a 38% reduction in the odds of anxiety after childbirth. In a separate 12-week trial of patients with Alzheimer's dementia, probiotic supplementation improved scores on standard cognitive tests (the Mini-Mental State Examination and the Montreal Cognitive Assessment) compared with an active control group, alongside reductions in inflammatory markers. Two smaller trials in people with IBS, a condition with a well-documented gut-brain component, also reported improvements in anxiety and depression symptoms alongside the digestive intervention.

Twenty Trials, 1,916 People, Four to 12 Weeks of Treatment

To be included, a trial had to be a randomized, placebo-controlled study in adults, lasting at least two weeks, with at least 20 participants and a validated measure of depression, anxiety, stress, sleep or cognition. Individual trial sizes ranged from 27 to 423 participants, and treatment periods ran from 4 to 12 weeks. Every trial was scored with the Cochrane Risk of Bias 2 tool, which grades study design across five domains; 15 of the 20 were rated low risk of bias and 5 were rated high risk. Most trials used single or multi-strain combinations of Lactobacillus and Bifidobacterium, the two genera most commonly marketed in over-the-counter probiotics, though a handful of trials also tested other species like Streptococcus thermophilus.

What This Means If You're Managing Your Own Mood, Sleep or Gut Health

For someone already dealing with depression, anxiety, poor sleep or a gut condition like IBS, this review is a reason for cautious interest rather than a green light to self-treat. The trials tested specific, named strains, not "probiotics" as a generic category, and the review does not identify one strain or dose as clearly superior. If you are considering a probiotic to help with mood or sleep, the most useful thing to bring to a conversation with a doctor is which strain a given product contains, since that is what the underlying trials actually varied by. Probiotics should be considered a possible complement to, not a replacement for, established treatments for depression or anxiety, and none of the studies in this review tested probiotics against standard antidepressant medication or therapy.

Study Quality Varied and Stress Hormone Results Were Mixed

The review's authors are explicit that heterogeneity, meaning the trials differed widely in the strains tested, the populations studied, the outcome scales used and the length of treatment, limits how confidently the findings can be pooled. Cortisol, the primary stress hormone, was measured in seven of the trials: four found a significant reduction in the probiotic group, while three found no significant change. Five of the 20 included trials were rated high risk of bias, meaning their design had weaknesses serious enough to question their results. A 2025 meta-analysis of prebiotic and probiotic trials in clinically diagnosed samples reached a similarly qualified conclusion, that the evidence is promising but not yet definitive.

Researchers Call for Larger, More Standardized Trials Next

The review's authors conclude that current evidence supports probiotics as beneficial for depressive symptoms, anxiety, sleep quality, gut microbial composition, quality of life and cognitive function, while stress hormone effects remain unresolved. They explicitly call for further well-designed RCTs that use standardized outcome measures and strains, arguing that the current mix of scales and interventions makes it hard to compare results across studies or pool them into firmer conclusions. No timeline for such trials is given in the review itself.

Common Questions

Can probiotics treat depression or anxiety on their own? The trials reviewed here tested probiotics as a supplement, not as a replacement for therapy or medication, and none compared probiotics head-to-head against standard antidepressant treatment. Talk to a doctor before changing or stopping any existing treatment.

Which probiotic strains were studied? Most of the 20 trials used strains of Lactobacillus or Bifidobacterium, sometimes in single-strain form and sometimes combined with other species like Streptococcus thermophilus. The review does not single out one strain as the most effective across outcomes.

How long did people take probiotics before seeing an effect? The trials in this review ran from 4 to 12 weeks, and benefits for depression, anxiety and sleep were generally reported within that window, not overnight.

Do probiotics lower cortisol, the stress hormone? The evidence is mixed. Four of the seven trials that measured cortisol found a significant reduction in the probiotic group, while three found no meaningful change, so this remains an open question.

References

1. Monalisa Das, Nooruddin Thajuddin, Gangatharan Muralitharan, et al. (2026). From Gut to Mind: Impact of Probiotics on Depression, Anxiety, Mood, Gut Microbiota, Sleep and Stress—A Systematic Review of RCTs. Annals of Neurosciences. https://doi.org/10.1177/09727531261478458
2. Gut microbiota's effect on mental health: The gut-brain axis. NIH. https://pmc.ncbi.nlm.nih.gov/articles/PMC5641835/
3. Afrida Asad, Megan Kirk, Sufen Zhu, Xue Dong, Min Gao (2024). Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuae177